Evidence map›Paper›PMID 18981230›Full record

ArticleThe Journal of cell biology2008

The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death.

Yohannes A Mebratu, Burton F Dickey, Chris Evans, Yohannes Tesfaigzi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.Journal of experimental & clinical cancer research : CR · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection.American journal of respiratory cell and molecular biology · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yohannes A MebratuLovelace Respiratory Research Institute, Albuquerque, NM 87108, USA.
Burton F Dickey
Chris Evans
Yohannes Tesfaigzi
Lovelace Respiratory Research Institute · USThe University of Texas MD Anderson Cancer Center · US

Funding

Resolution of Epithelial Cell Hyperplasia in AsthmaR01HL068111 · NHLBI · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2003 to 2021
$10.9M
ENDOTOXIN INDUCED MUCOUS CELL METAPLASIAR01ES009237 · NIEHS · LOVELACE BIOMEDICAL &ENVIRONMENTAL RES · PI TESFAIGZI, YOHANNES · 1999 to 2003
$1.4M
Regulation of Mucous Cell Metaplasia in AsthmaR56HL068111 · NHLBI · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2007 to 2007
$500k
NCRR NIH HHS 5M01 RR099NHLBI NIH HHS HL68111NHLBI NIH HHS R01 HL068111NHLBI NIH HHS R56 HL068111NIEHS NIH HHS ES09237NIEHS NIH HHS R01 ES009237
6 · The paper itself

Abstract

IFNgamma induces cell death in epithelial cells, but the mediator for this death pathway has not been identified. In this study, we find that expression of Bik/Blk/Nbk is increased in human airway epithelial cells (AECs [HAECs]) in response to IFNgamma. Expression of Bik but not mutant BikL61G induces and loss of Bik suppresses IFNgamma-induced cell death in HAECs. IFNgamma treatment and Bik expression increase cathepsin B and D messenger RNA levels and reduce levels of phospho-extracellular regulated kinase 1/2 (ERK1/2) in the nuclei of bik(+/+) compared with bik(-/-) murine AECs. Bik but not BikL61G interacts with and suppresses nuclear translocation of phospho-ERK1/2, and suppression of ERK1/2 activation inhibits IFNgamma- and Bik-induced cell death. Furthermore, after prolonged exposure to allergen, hyperplastic epithelial cells persist longer, and nuclear phospho-ERK is more prevalent in airways of IFNgamma(-/-) or bik(-/-) compared with wild-type mice. These results demonstrate that IFNgamma requires Bik to suppress nuclear localization of phospho-ERK1/2 to channel cell death in AECs.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAnnexin A5Apoptosis Regulatory ProteinsBH3 Interacting Domain Death Agonist ProteinCathepsin BCathepsin DCell DeathCell DivisionCell NucleusEpithelial CellsHumansInterferon-gammaMembrane ProteinsMiceMice, KnockoutAdaptor Proteins, Signal TransducingAnnexin A5Apoptosis Regulatory ProteinsBH3 Interacting Domain Death Agonist ProteinBID protein, humanBIK protein, humanBik protein, mouseCathepsin BCathepsin Dhairpin ribozymeInterferon-gammaMembrane ProteinsMitochondrial ProteinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3RNA, Catalytic

Identifiers

PMID18981230
PMCPMC2575785
OpenAlexW2163469549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.